World's Best Scientists 2026 revealed!
Christophe Hézode

Christophe Hézode

D-Index & Metrics

Medicine

D-Index
81
Citations
25442
World Ranking
16579
National Ranking
542

Overview

Christophe Hézode is affiliated with Université Paris Cité in France. Their research primarily spans the field of Medicine, with a focus on epidemiology, hepatology, and infectious diseases. This work encompasses studies related to liver diseases, viral infections, and treatments.

The scientist's recent publications highlight a strong interest in liver disease diagnosis and treatment as well as viral hepatitis. Notable papers include:

  • Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials (2020, Journal of Hepatology)
  • Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta (2020, Journal of Hepatology)
  • Assessing Molecular Point-of-Care Testing and Dried Blood Spot for Hepatitis C Virus Screening in People Who Inject Drugs (2020, Open Forum Infectious Diseases)
  • Evaluation of the Xpert HBV Viral Load for hepatitis B virus molecular testing (2020, Journal of Clinical Virology)
  • Performance of rapid diagnostic tests for hepatitis B surface antigen detection in serum or plasma (2021, Diagnostic Microbiology and Infectious Disease)

Frequent co-authors who have collaborated with Hézode include:

  • Stéphane Chevaliez
  • Jean-Michel Pawlotsky
  • Françoise Roudot-Thoraval
  • Isabelle Rosa
  • V. Loustaud-Ratti

Hézode's research has been published predominantly in medical journals specializing in liver and viral diseases. The main publication venues include:

  • Journal of Hepatology
  • Journal of Clinical Virology
  • Open Forum Infectious Diseases
  • Viruses
  • Diagnostic Microbiology and Infectious Disease

Their main areas of study reflect a focus on:

  • Hepatitis C virus research
  • Liver Disease Diagnosis and Treatment
  • Hepatitis B Virus Studies
  • Liver Disease and Transplantation
  • HIV/AIDS drug development and treatment
  • Hepatitis Viruses Studies and Epidemiology
  • Viral Infections and Outbreaks Research

This profile indicates a dedicated involvement in hepatology and viral infectious disease research, reflected through contributions to understanding hepatitis viruses and improving screening and diagnostic methods. The collaboration network includes several frequent co-authors contributing to this scientific domain alongside Hézode.

Best Publications

  • Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

    Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen

  • Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.

    Christophe Hézode;Nicole Forestier;Geoffrey Dusheiko;Peter Ferenci

  • Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

    Jordan J. Feld;Ira M. Jacobson;Christophe Hézode;Tarik Asselah

  • ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

    Fred Poordad;Christophe Hezode;Roger Trinh;Kris V. Kowdley

  • Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3

    Stefan Zeuzem;Geoffrey M. Dusheiko;Riina Salupere;Alessandra Mangia

  • Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

    Fabrice Carrat;Hélène Fontaine;Céline Dorival;Mélanie Simony

  • Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890

    Christophe Hézode;Hélène Fontaine;Céline Dorival;Dominique Larrey

  • Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study.

    Christophe Duvoux;David Zanditenas;Christophe Hézode;Anthony Chauvat

  • Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients

    Keyur Patel;Stuart C. Gordon;Ira Jacobson;Christophe Hézode

  • Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.

    Christophe Hézode;Christophe Hézode;Françoise Roudot-Thoraval;Françoise Roudot-Thoraval;Son Nguyen;Pascale Grenard

  • Historical epidemiology of hepatitis C virus (HCV) in selected countries

    P. Bruggmann;T. Berg;A. L. H. Øvrehus;C. Moreno

  • Antiviral strategies in hepatitis C virus infection.

    Christoph Sarrazin;Christophe Hézode;Christophe Hézode;Stefan Zeuzem;Jean-Michel Pawlotsky;Jean-Michel Pawlotsky

  • Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial

    Mark Sulkowski;Christophe Hezode;Jan Gerstoft;John M Vierling

  • Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies

    Castéra L;Hézode C;Roudot-Thoraval F;Bastie A

  • Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)

    Marc Bourlière;Jean Pierre Bronowicki;Victor de Ledinghen;Christophe Hézode

  • Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

    Christophe Hézode;Tarik Asselah;K Rajender Reddy;Tarek Hassanein

  • Antiviral action of ribavirin in chronic hepatitis C.

    Jean Michel Pawlotsky;Harel Dahari;Avidan U. Neumann;Christophe Hezode

  • Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis

    Christophe Hézode;Helene Fontaine;Celine Dorival;Fabien Zoulim

  • Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+)

    Vincent Leroy;Peter W Angus;Jean-Pierre Bronowicki;Gregory J Dore

  • Strategies to manage hepatitis C virus (HCV) disease burden

    H Wedemeyer;A S Duberg;M Buti;W M Rosenberg

Frequent Co-Authors

Stanislas Pol
Stanislas Pol Université Paris Cité
Françoise Roudot-Thoraval
Françoise Roudot-Thoraval Assistance Publique – Hôpitaux de Paris
Dominique Larrey
Dominique Larrey University of Montpellier
Jean-Pierre Bronowicki
Jean-Pierre Bronowicki University Hospital of Nancy
Marc Bourlière
Marc Bourlière Hôpital Saint Joseph
Daniel Dhumeaux
Daniel Dhumeaux Grenoble Alpes University
Laurent Alric
Laurent Alric Federal University of Toulouse Midi-Pyrénées
Albert Tran
Albert Tran Inserm : Institut national de la santé et de la recherche médicale

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in flexible routes to a career in healthcare, online medical and nursing programs offer a range of accelerated and convenient pathways. Many choose accelerated dnp programs to earn their Doctor of Nursing Practice degree more efficiently, paving the way for leadership roles in clinical settings.

If you’re seeking a less intensive route, there are also easiest dnp programs that focus on balancing rigorous training with manageable course structures, appealing to working professionals.

Aspiring nurses looking for a quick start may consider fast track lpn programs online, which allow students to qualify as Licensed Practical Nurses in less time than traditional programs.

For those interested in mental health care, accelerated msn psychiatric np programs provide a fast pathway to becoming a Psychiatric Mental Health Nurse Practitioner—a role in growing demand across the country.

These options allow students to advance their medical careers with flexibility, making healthcare education more accessible than ever.

Best Scientists Citing Christophe Hézode

Trending Scientists

Recently Published Articles